Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
CNBC·6/8/2026, 2:30:37 PM
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Read full article →Get the daily Biz Vault
Free, daily, no spam.